Quentin Blackford, President & CEO at iRhythm Technologies, Inc.:
In 2022, expect remote patient monitoring to expand as patients and providers rely more heavily on actionable insights from uninterrupted health data. Reactive diagnosis is an insufficient method in preventing negative outcomes, and clinicians will continue to find more value in preemptive, proactive screening.
COVID-19 accelerated the shift toward remote care, and the coming months will likely see increased acceptance of the evolving technology across a variety of stakeholders.
Additionally, companies will continue to work towards improving accessibility for at-risk patient populations. The pandemic exacerbated healthcare access issues for millions, and the medtech industry will prioritize solutions to get care to those that need it most.
This article was original published here.